⌘K

Home/Filings/4/0001213900-18-015546

4//SEC Filing

Johnson Bankole A. 4

Accession 0001213900-18-015546

CIK 0001513525other

View on SEC.gov Company Profile

Filed

Nov 12, 7:00 PM ET

Accepted

Nov 13, 6:01 PM ET

Size

10.0 KB

Accession

0001213900-18-015546

Insider Transaction Report

Form 4

Period: 2018-11-12

ADIAL PHARMACEUTICALS, INC.ADIL

Johnson Bankole A.

Director10% Owner

Transactions

Other
Warrant to purchase units
2018-11-12−17,600→ 0 total
Exercise: $5.00From: 2018-07-31Exp: 2023-07-31→ Units (35,200 underlying)
Other
Warrant to purchase common stock
2018-11-12+17,600→ 17,600 total
Exercise: $6.25From: 2018-11-12Exp: 2023-07-31→ Common Stock (17,600 underlying)
Other
Warrant to purchase common stock
2018-11-12+17,600→ 17,600 total
Exercise: $5.00From: 2018-11-12Exp: 2023-07-31→ Common Stock (17,600 underlying)

Footnotes (1)

[F1]On November 12, 2018, Bankole Johnson exchanged a warrant to purchase 17,600 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 17,600 shares of common stock.

Documents

1 file

4
ownership.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

ADIAL PHARMACEUTICALS, INC.

CIK 0001513525

Entity typeother

Related Parties

1

filerCIK 0001718158

Filing Metadata

Form type: 4
Filed: Nov 12, 7:00 PM ET
Accepted: Nov 13, 6:01 PM ET
Size: 10.0 KB

View on SEC.gov